Abstract
Computer-aided drug discovery (CADD) is a widely used method for drug discovery with many successes. Meanwhile, CADD has the limitation of analyzing multi-level scores such as docking results of multiple proteins with multiple drugs. We propose a method of PageRank to solve the problem. This method can make a comprehensive ranking based on multi-level scores. Then we take an example of therapeutic hypothermia (TH). Three levels of TH data were used in the article: the log2 foldchange (logFC) of proteins, the relative expression values of mRNA, and the docking scores of proteins and molecules. After calculation, we get the comprehensive drug rank and drug combination rank of each group of TH, which means we can generate the rank of drug directly from bioinformatics. Based on this method, we raised the concept of bioinfo-pharmacology. Given the high rationality and compatibility of bioinfo-pharmacology, it can effectively enhance popular drug discovery techniques such as the docking or pharmacophore model. Besides, it could advance the application of precision medicine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NO FUND.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# The first 1 author is the first author.
Declaration
Ethics approval and consent to participate. Not applicable.
Consent for publication All authors allow the publication of this article.
Availability of data and materials All the data that support the findings of this study are available for email from authors.
Competing interests The authors have declared that they have no conflicts or interests.
Funding The authors have stated that no such relationships exist.